News
FDA expands approval of Moderna's RSV vaccine
Digest more
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...
A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...
Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the ...
The global respiratory syncytial virus respiratory syncytial virus treatment market is undergoing rapid growth, driven by ...
The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback